Sterile Compounding Pharmacies Market Scope And Analysis

  • Report Code : TIPRE00026302
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 163
Buy Now

Sterile Compounding Pharmacies Market Scope and Key Players Analysis by 2028

Buy Now


Sterile Compounding Pharmacies Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.97 Billion
Market Size by 2028 US$ 6.2 Billion
Global CAGR (2021 - 2028) 6.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Injectable Drugs and Infusions
By Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Fagron Inc
  • Triangle Compounding Pharmacy
  • B Braun Melsungen AG
  • PharMedium Healthcare Holdings Inc
  • Fresenious Kabi AG
  • Avella Specialty Pharmacy
  • Pencol Compounding Pharmacy
  • Pavilion Compounding Pharmacy LLC
  • Pace Pharmacy
  • Route of Administration-Based Insights

    Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous. The intravenous segment held the largest share of the market in 2020 and is projected to continue its dominance during the forecast period. However, the intramuscular segment is estimated to register the highest CAGR in the market during the forecast period. The intramuscular (IM) route of drug delivery is the most common route for parenteral injection. Many antibiotics, preoperative sedatives, and narcotics are given through the intramuscular route. For instance, in February 2021, Biogen, announced that the US Food and Drug Administration (FDA) approved a new intramuscular (IM) injection for "Plegridy (peginterferon beta-1a) responsible for treating multiple sclerosis (MS).

    Companies operating in the sterile compounding pharmacies market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

    Based on product, the sterile compounding pharmacies market is bifurcated into injectables and infusions.

    Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous

    Sterile Compounding Pharmacies Market Size – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM


    Company Profiles

    • Fagron, Inc.
    • Triangle Compounding Pharmacy
    • B. Braun Melsungen AG
    • PharMedium Healthcare Holdings, Inc.
    • Fresenius Kabi AG
    • Avella specialty Pharmacy
    • Pencol Compounding Pharmacy
    • Pavilion Compounding Pharmacy LLC
    • Pace Pharmacy
    • SandsRx